Skip to main content
. 2016 Jan 4;7(3):316–322. doi: 10.1111/1759-7714.12330

Figure 4.

figure

Kaplan–Meier analysis of overall survival in stage I pulmonary adenocarcinoma patients. The five‐year survival rate of stage I pulmonary adenocarcinoma patients with centrosomal protein 55 (CEP55) overexpression versus patients without CEP55 overexpression.